Prognostic impact of the e-TAPSE ratio in intermediate-high risk pulmonary embolism patients

被引:0
|
作者
Zuin, Marco [1 ,2 ]
Bilato, Claudio [1 ]
Bongarzoni, Amedeo [3 ]
Zonzin, Pietro [4 ]
Casazza, Franco [5 ]
Roncon, Loris [4 ]
机构
[1] West Vicenza Hosp, Dept Cardiol, Arzignano, Vicenza, Italy
[2] Univ Ferrara, Dept Translat Med, I-44124 Ferrara, Italy
[3] Univ Milan, Dept Cardiol, ASST Santi Paolo & Carlo, Milan, Italy
[4] Santa Maria Misericordia Hosp, Dept Cardiol, Rovigo, Italy
[5] San Carlo Borromeo Hosp, Dept Cardiol, Milan, Italy
来源
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING | 2024年 / 40卷 / 03期
关键词
Pulmonary embolism; Clinical deterioration; Mean arterial pressure; RIGHT-VENTRICULAR DYSFUNCTION; NORMOTENSIVE PATIENTS; GUIDELINES; MANAGEMENT; SEVERITY; PRESSURE; SOCIETY; INDEX; AGE;
D O I
10.1007/s10554-023-03010-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We assess the prognostic role of a new index (Age-T index), based on age and the tricuspid annular plane systolic excursion (TAPSE) for the estimation of 30-day mortality and risk of 48-h clinical deterioration since admission, in intermediate-high risk Pulmonary Embolism (PE) patients. A post-hoc analysis of intermediate-high risk PE patients enrolled in the Italian Pulmonary Embolism Registry (IPER) (Trial registry: ClinicalTrials.gov; No.: NCT01604538) was performed. The Age-T index was calculated as the ratio between age and TAPSE. The primary outcome was the 30-day mortality risk while the risk of clinical deterioration within 48 h in the same patients was chosen as the secondary outcome. Among 450 intermediate-high risk PE patients (mean age 71.4 +/- 13.8 years, 298 males), 40 (8.8%) experienced clinical deterioration within 48 h since admission and 32 (7.1%) died within 30-day. Receiver operating characteristic analysis established >= 4.9 as the optimal cut-off value for the Age-T index in predicting 30-day mortality (AUC of 0.76 +/- 0.1). Sensitivity, specificity, PPV and NPV were 81.2, 85.6, 30.2 and 98.3%, respectively. Multivariate Cox regression analysis showed that an Age-T index >= 4.9 predicts 30-day mortality (HR: 3.24, 95% CI: 1.58-4.96, p < 0.001) and was also associated with a significantly higher risk of 48-h clinical deterioration (HR: 2.02, 95% CI 1.96-2.08, p < 0.0001) in intermediate-high risk PE patients. Age-T Index appears as a useful, bed-side and non-invasive prognostic tool to identify intermediate-high risk PE patients at higher risk of death and/or 48-h clinical deterioration.
引用
收藏
页码:467 / 476
页数:10
相关论文
共 50 条
  • [31] Single-center experience on ultrasound-facilitated thrombolysis in patients with pulmonary embolism at high risk or intermediate-high risk
    Kaymaz, C.
    Akbal, O.
    Yilmaz, F.
    Ozturk, S.
    Tanboga, I.
    Turkday, S.
    Hakgor, A.
    Poci, N.
    Safak, A.
    Yildiz, C.
    Tokgoz, H.
    Ozdemir, N.
    EUROPEAN HEART JOURNAL, 2016, 37 : 755 - 755
  • [32] EARLY PRESCRIPTION OF DIRECT ORAL ANTICOAGULANTS FOR ACUTE INTERMEDIATE-HIGH RISK PULMONARY EMBOLISM
    Chopard, Romain
    Eveno, Charly
    Humbert, Sebastien
    Falvo, Nicolas
    Morel, Mathilde
    Bonnet, Benjamin
    Napporn, Gabriel
    Kalbacher, Elsa
    Obert, Laurent
    Degano, Bruno
    Capellier, Gilles
    Cottin, Yves
    Schiele, Francois
    Meneveau, Nicolas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1908 - 1908
  • [33] MULTIDISCIPLINARYAPPROACH TO INTERMEDIATE-HIGH RISK PULMONARY EMBOLISM: FROM BEDSIDE ASSESSMENT TO THE ANGIOGRAPHY ROOM
    Occhi, L.
    Musca, F.
    Sacco, A.
    Morici, N.
    De Chiara, B.
    Moreo, A.
    Bossi, I.
    Rampoldi, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G38 - G39
  • [34] Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism
    Surgit, Ozgur
    Guner, Ahmet
    Turkmen, Irem
    Kahraman, Serkan
    Serbest, Nail Guven
    Guener, Ezgi Gultekin
    Uzun, Fatih
    Erturk, Mehmet
    Yildiz, Mustafa
    ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY, 2023, 29 (06): : 677 - 684
  • [35] Impact of percutaneous treatment of acute pulmonary embolism in intermediate and high risk patients
    Farre, N.
    Miranda, F.
    Orozco-Levi, M.
    Salvatella, N.
    Tizon, H.
    Molina, L.
    Gea, J.
    Bruguera, J.
    EUROPEAN HEART JOURNAL, 2012, 33 : 713 - 713
  • [36] Elective endovascular reperfusion therapies in intermediate-high risk pulmonary embolism after PERT assesment
    Cigalini, I
    Najenson, M.
    Petry, C.
    Cardona, M.
    Balparda, H.
    Montiel, F.
    Montenegro, M.
    Cabral, L.
    Fedele, J.
    Gumpel, C.
    Depaoli, C.
    Polillo, D.
    Zarria, L.
    Cigalini, C.
    Dumont, C.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [37] Safety and efficacy of percutaneous catheter-directed treatment for intermediate-high risk pulmonary embolism
    Rumiz Gonzalez, E.
    Vilar Herrero, J. V.
    Escriva, G. M.
    Vidal Urrutia, V.
    Fernandez Cisnal, A.
    Cubillos Arango, A.
    Nunez Villota, J.
    Berenguer Jofresa, A.
    Sanchis Fores, J.
    Valero Picher, E.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1936 - 1936
  • [38] Intermediate-High Risk Pulmonary Embolism: Time Matters. The Case of a Young Breastfeeding Woman
    Mennuni, Marco Giovanni
    Grisafi, Leonardo
    Solli, Martina
    D'Amario, Domenico
    De Crescenzo, Francesco
    Galiffa, Vincenzo
    Rosso, Roberta
    Patti, Giuseppe
    GIORNALE ITALIANO DI CARDIOLOGIA, 2024, 25 (12) : 888 - 890
  • [39] A novel hybrid catheter-directed technique to treat intermediate-high risk pulmonary embolism
    Slawek-Szmyt, Sylwia L.
    Jankiewicz, Stanislaw
    Grygier, Marek
    Lesiak, Maciej
    Araszkiewicz, Aleksander
    CARDIOLOGY JOURNAL, 2022, 29 (02) : 342 - 345
  • [40] PERIPARTUM PULMONARY EMBOLISM: SUCCESSFUL MECHANICAL THROMBECTOMY OF AN INTERMEDIATE-HIGH RISK PE BEFORE DELIVERY
    Parikh, Amish
    Morel, Karla J. Cruz
    CHEST, 2024, 166 (04) : 5713A - 5714A